Altimmune, Inc. (ALT)
3.155
-0.04
(-1.41%)
USD |
NASDAQ |
Aug 26, 16:00
3.16
0.00 (0.00%)
After-Hours: 20:00
Altimmune Total Assets (Quarterly) : 527.21M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 527.21M |
| March 31, 2026 | 335.63M |
| December 31, 2025 | 279.93M |
| September 30, 2025 | 218.45M |
| June 30, 2025 | 190.35M |
| March 31, 2025 | 157.26M |
| December 31, 2024 | 139.31M |
| September 30, 2024 | 147.86M |
| June 30, 2024 | 173.35M |
| March 31, 2024 | 188.36M |
| December 31, 2023 | 210.64M |
| September 30, 2023 | 166.57M |
| June 30, 2023 | 183.32M |
| March 31, 2023 | 187.08M |
| December 31, 2022 | 206.93M |
| September 30, 2022 | 225.28M |
| June 30, 2022 | 209.91M |
| March 31, 2022 | 205.66M |
| December 31, 2021 | 218.86M |
| September 30, 2021 | 236.91M |
| June 30, 2021 | 257.26M |
| March 31, 2021 | 264.25M |
| December 31, 2020 | 245.12M |
| September 30, 2020 | 233.00M |
| June 30, 2020 | 102.54M |
| Date | Value |
|---|---|
| March 31, 2020 | 54.23M |
| December 31, 2019 | 54.06M |
| September 30, 2019 | 56.39M |
| June 30, 2019 | 61.98M |
| March 31, 2019 | 65.37M |
| December 31, 2018 | 54.75M |
| September 30, 2018 | 52.86M |
| June 30, 2018 | 52.10M |
| March 31, 2018 | 60.87M |
| December 31, 2017 | 63.03M |
| September 30, 2017 | 74.35M |
| June 30, 2017 | 90.84M |
| March 31, 2017 | 20.73M |
| December 31, 2016 | 38.40M |
| September 30, 2016 | 140.54M |
| June 30, 2016 | 27.93M |
| March 31, 2016 | 18.73M |
| December 31, 2015 | 19.86M |
| September 30, 2015 | 20.90M |
| June 30, 2015 | 22.62M |
| March 31, 2015 | 25.47M |
| December 31, 2014 | 21.98M |
| September 30, 2014 | 23.35M |
| June 30, 2014 | 15.22M |
| March 31, 2014 | 14.37M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Amgen, Inc. | 95.64B |
| Protalix Biotherapeutics, Inc. | 110.34M |
| Taysha Gene Therapies, Inc. | 470.43M |
| Humacyte, Inc. | 138.09M |
| Liquidia Corp. | 521.92M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 53.00M |
| Shareholders Equity (Quarterly) | 474.21M |
| Debt to Equity Ratio | 0.076 |
| Current Ratio | 26.77 |
| Net Debt Paydown Yield | -1.16% |